ALB and neoplasm: Covalent conjugation chemically attaches drugs to albumin with the help of cleavable linkers that respond to tumor-specific stimuli such as low pH, hypoxia, or tumor-overexpressing enzymes, which allows targeted drug release in the tumor microenvironment with reduced systemic toxicity.